Cargando…
Therapeutic Potential of Cannabinoids in Glaucoma
Glaucoma is a leading cause of irreversible blindness worldwide. To date, intraocular pressure (IOP) is the only modifiable risk factor in glaucoma treatment, but even in treated patients, the disease can progress. Cannabinoids, which have been known to lower IOP since the 1970s, have been shown to...
Autores principales: | Lindner, Theresa, Schmidl, Doreen, Peschorn, Laura, Pai, Viktoria, Popa-Cherecheanu, Alina, Chua, Jacqueline, Schmetterer, Leopold, Garhöfer, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460067/ https://www.ncbi.nlm.nih.gov/pubmed/37631064 http://dx.doi.org/10.3390/ph16081149 |
Ejemplares similares
-
Gender Differences in Ocular Blood Flow
por: Schmidl, Doreen, et al.
Publicado: (2015) -
Retinal Oxygen Extraction in Patients with Primary Open-Angle Glaucoma
por: Garhöfer, Gerhard, et al.
Publicado: (2022) -
Effect of increased oxygen tension on flicker-induced vasodilatation in the human retina
por: Palkovits, Stefan, et al.
Publicado: (2014) -
Optic nerve head blood flow regulation during changes in arterial blood pressure in patients with primary open‐angle glaucoma
por: Bata, Ahmed M., et al.
Publicado: (2018) -
Ocular perfusion pressure and ocular blood flow in glaucoma
por: Cherecheanu, A Popa, et al.
Publicado: (2013)